Irith Wiegand
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 22
- Microbiology top 0.1%
- Antimicrobial Peptides and Activities 5
- Endocrinology top 1%
- Food Science top 0.5%
-
- Bacterial biofilms and quorum sensing 10
-
- Urinary Tract Infections Management 8
-
- Pediatric Urology and Nephrology Studies 5
-
- Pharmaceutical and Antibiotic Environmental Impacts 4
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Cystic Fibrosis Research Advances 3
- Co-authors
- Robert E. W. HancockKai HilpertManjeet BainsLucía FernándezW. James GooderhamJosé Luis MartínezJorge Olivares‐PachecoCarolina Alvarez‐Ortega
In The Last Decade
Irith Wiegand
27 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Medicine 1.9k
- Microbiology 1.7k
- Endocrinology 487
- Applied Microbiology and Biotechnology 173
- Food Science 950
Countries citing papers authored by Irith Wiegand
This map shows the geographic impact of Irith Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irith Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irith Wiegand more than expected).
Fields of papers citing papers by Irith Wiegand
This network shows the impact of papers produced by Irith Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irith Wiegand. The network helps show where Irith Wiegand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Irith Wiegand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 6 | |
| 2 | 2021 | 7 | |
| 3 | 2019 | 36 | |
| 4 | Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study | 2018 | 2 |
| 5 | 2018 | 48 | |
| 6 | 2018 | 47 | |
| 7 | 2018 | 33 | |
| 8 | 2016 | 6 | |
| 9 | 2012 | 119 | |
| 10 | 2011 | 75 | |
| 11 | 2010 | 129 | |
| 12 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesbreakdown → | 2008 | 4683 |
| 13 | 2008 | 131 | |
| 14 | 2007 | 149 | |
| 15 | 2007 | 28 | |
| 16 | 2007 | 138 | |
| 17 | 2006 | 66 | |
| 18 | 2005 | 12 | |
| 19 | 2004 | 9 | |
| 20 | 1998 | 24 |
About Irith Wiegand
Irith Wiegand is a scholar working on Molecular Medicine, Microbiology and Endocrinology, having authored 27 papers that have together received 6.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Bacterial biofilms and quorum sensing (10 papers), Urinary Tract Infections Management (8 papers), Antimicrobial Peptides and Activities (5 papers), Pediatric Urology and Nephrology Studies (5 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Cystic Fibrosis Research Advances (3 papers). The work is most often cited by research in Molecular Medicine (1.9k citations), Microbiology (1.7k citations) and Endocrinology (487 citations). Irith Wiegand has collaborated with scholars based in Canada, Spain and Germany. Frequent co-authors include Robert E. W. Hancock, Kai Hilpert, Manjeet Bains, Lucía Fernández, W. James Gooderham, José Luis Martínez, Jorge Olivares‐Pacheco, Carolina Alvarez‐Ortega, Joseph B. McPhee and Joerg Overhage. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, BMJ Open, Antimicrobial Resistance and Infection Control, Journal of Bacteriology and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.